The Valley Desk

Publications on Disease research from Johnson & Johnson

A filtered view. Show the full list.

Refine

89 publications · listings 1–24

Listings

  1. ArticleACR open rheumatology

    Macrophage Activation Syndrome-Associated Proteins and Enhanced Interferon-γ Responsiveness in the Plasma Proteome of Patients With Multisystem Inflammatory Syndrome in Children in a Pretreatment Replication Single-Center Cohort

    Verified Author affiliations on the Europe PMC record name Children’s Hospital of Philadelphia, Johnson & Johnson. Affiliation source

    Disease researchAdded

  2. ArticleACR open rheumatology

    Reproducible Molecular Subtypes in Systemic Lupus Erythematosus Are Associated With Disease Activity, Serology, and Distinct Trajectories Over Time

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Disease researchAdded

  3. ArticlePregnancy (Hoboken, N.J.)

    Characterization of the clinical course of early-onset severe hemolytic disease of the fetus and newborn

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Disease researchAdded

  4. ArticleAnalytical and bioanalytical chemistry

    Polyclonal antibodies targeting defined epitopes on cancer biomarker MUC16

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Disease researchAdded

  5. ArticleDermatology and therapy

    The Impact of Post-inflammatory Pigment Alteration After Psoriasis: Novel Data from the VISIBLE Study

    Verified Author affiliations on the Europe PMC record name Johnson & Johnson, University of Pennsylvania. Affiliation source

    Disease researchAdded

  6. ArticleAnnals of the rheumatic diseases

    PD-1 signalling restrains pathogenic T peripheral helper and effector CD4⁺ T cell functions in rheumatoid arthritis

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Disease researchAdded

  7. ArticleCell

    Human genetics guides the discovery of CARD9 inhibitors with anti-inflammatory activity

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Disease researchAdded

  8. ArticleCell reports

    Combining genotoxic gut bacterial strains increases tumor burden and accelerates onset in a germ-free mouse model of colon carcinogenesis

    Listed An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Disease researchAdded

  9. ArticleCell host & microbe

    Defined human Clostridia consortia reverse colitis via dual effects of tryptophan metabolites on microbiota and immunity

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Disease researchAdded

  10. ArticleClinical lymphoma, myeloma & leukemia

    Teclistamab Response- and Relapse-Related Immune Correlates in the MajesTEC-1 China Cohort

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Disease researchAdded

  11. Clinical trial reportJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

    Long-Term Impact of First-Line Amivantamab Plus Lazertinib Versus Osimertinib on Mechanisms of Acquired Resistance in MARIPOSA: A Brief Report

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Disease researchAdded

  12. ArticleJournal of chemical information and modeling

    Quantum Pharmacophore-Based Virtual Screening Enables Prospective Discovery of Chemotype-Diverse Dengue NS5 Inhibitors

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Disease researchAdded

  13. ArticleJournal of medicinal chemistry

    Optimization of Covalent 6-Cyanoquinazoline KRASG12C Inhibitors for the Treatment of Solid Tumors

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Disease researchAdded

  14. ArticleACS medicinal chemistry letters

    Discovery of 5‑Azaindole Inhibitors of O‑GlcNAcase for the Treatment of Alzheimer's Disease and Related Tauopathies

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Disease researchAdded

  15. ArticleNature communications

    Single-cell transcriptome reveals keratinocyte subclusters contributing to altered differentiation and inflammatory responses in atopic dermatitis

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Disease researchAdded

  16. ArticleNature medicine

    Multimodal antigenic escape to GPRC5D-targeted T cell engagers in multiple myeloma

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Disease researchAdded

  17. ArticleLupus science & medicine

    Baseline characteristics of patients with SLE with and without lupus nephritis from the Latin American multiethnic GLADEL 2.0 cohort

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Disease researchAdded

  18. ArticleLupus science & medicine

    Demographic and clinical characteristics of patients with systemic lupus erythematosus across five registries: the LupusNet federated data network

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Disease researchAdded

  19. ArticleBlood cancer discovery

    Preclinical characterization of the potent and selective MALT1 inhibitor safimaltib in B-cell lymphoma models

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Disease researchAdded

  20. ArticleCirculation. Heart failure

    Cost of Idling: Skeletal Muscle Myosin ATPase Dysfunction and the Energetic Basis of Exercise Intolerance in HFrEF

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Disease researchAdded

  21. ArticleJournal of circulating biomarkers

    Circulating free and low-density lipoprotein-bound GD2 can compete in vitro with neuroblastoma cells for binding therapeutic anti-GD2 antibodies

    Verified Author affiliations on the Europe PMC record name Children’s Hospital of Philadelphia, Johnson & Johnson, Perelman School of Medicine, University of Pennsylvania. Affiliation source

    Disease researchAdded

  22. EditorialFrontiers in immunology

    Editorial: Advances in therapeutic cancer vaccines-mechanisms and development

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Disease researchAdded

  23. ArticleVision (Basel, Switzerland)

    Real-World Comparison of Overall Survival Among Patients With and Without Inherited Retinal Diseases

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Disease researchAdded

  24. PreprintbioRxiv

    Menaquinone depletion resensitises bedaquiline-resistant tuberculosis

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Disease researchAdded